Nuacht

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...
Changes are happening around COVID-19 vaccines: Here's what to know
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...
FDA Updates COVID-19 Vaccine Regulations—Here’s What to Know
The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to ...
Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine
CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...
BioSpace1 lá
FDA Vaccine Advisors Agree on COVID-19 Vaccine as New Framework Looms as ‘Elephant in the Room’
The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.
FDA limits access to COVID-19 vaccine to older adults and other high-risk groups
On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.
Healio2 lá
FDA tells vaccine makers to expand warning labels on COVID-19 shots
The FDA has told vaccine manufacturers to expand the warning labels on their COVID-19 shots with more information about the ...
FDA requires COVID-19 vaccine makers to warn about risk of heart inflammation
FDA now requires Pfizer and Moderna COVID-19 vaccines to carry expanded warning labels about risks of myocarditis and pericarditis ...
Infectious Disease Advisor1 lá
FDA’s New COVID-19 Vaccine Approval Policy May Limit Future Access
The FDA is implementing stricter guidance for the approval of COVID-19 vaccines, according to a paper published in The New England Journal of Medicine.
Healio1 lá
FDA committee recommends formula for fall COVID-19 vaccines
An FDA committee on Thursday recommended that COVID-19 vaccines for the 2025-2026 respiratory virus season — which, for the ...
FDA tightens COVID-19 vaccine access, creates hurdles for healthy adults, kids
FDA's new COVID-19 vaccine policy may restrict low-risk individuals' access, pending clinical trials to prove benefits.